Chargement en cours...
Treatment of IgM antibody associated polyneuropathies using rituximab
Objectives: Polyneuropathies with associated serum IgM antibodies are often difficult to treat. Rituximab is a monoclonal antibody directed against the B cell surface membrane marker CD20. Rituximab eliminates B cells from the circulation, and, over time, could reduce cells producing autoantibodies....
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Group
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1738397/ https://ncbi.nlm.nih.gov/pubmed/12640069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.74.4.485 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|